InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by Culwell Kelly, Directeur Médical. Director active across 2 companies, notably Evofem Biosciences, Inc.. Cumulatively, 2 disclosures have been recorded. The latest transaction was filed on 20 May 2021 — Retenue fiscale. Regulator: SEC (Form 4). All data is free.
Declarations2 total
€29,58842,061 shares@ €0.7035100.0% of flow
Common Stock
SEC:0001618835-21-000135·
€29,58842,061 shares@ €0.70353.43% mcap100.0% of flow
Common Stock
SEC:0001618835-21-000135:0·
2 of 2 declarations
About Culwell Kelly
Kelly Culwell is the Chief Medical Officer at Evofem Biosciences, Inc. She is responsible for leading the company's medical initiatives and research and development strategy. Her role includes overseeing clinical trials and ensuring that products meet safety and efficacy standards. She plays a key role in innovation and the development of new treatments.
